Maximilian Merz (M Merz)

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 22

Top Venues

Leukemia

Nature cancer

Blood advances

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Luise Fischer, Nora Grieb, Patrick Born, Ronald Weiss, Sabine Seiffert, Andreas Boldt, Stephan Fricke, Paul Franz, Simone Heyn, Anne-Sophie Kubasch, Ronny Baber, Heike Weidner, Song-Yau Wang, Enrica Bach, Sandra Hoffmann, Jule Ussmann, Janine Kirchberg, Saskia Hell, Sebastian Schwind, Klaus H Metzeler, Marco Herling, Madlen Jentzsch, Georg-Nikolaus Franke, Ulrich Sack, Kristin Reiche, Ulrike Köhl, Uwe Platzbecker, Vladan Vucinic, Maximilian Merz
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma. Leukemia 38 (2) (2024)
Michael Rade, Nora Grieb, Ronald Weiss, Jaren Sia, Luise Fischer, Patrick Born, Andreas Boldt, Stephan Fricke, Paul Franz, Jonathan Scolnick, Lakshmi Venkatraman, Stacy Xu, Christina Kloetzer, Simone Heyn, Anne Sophie Kubasch, Ronny Baber, Song-Yau Wang, Enrica Bach, Sandra Hoffmann, Jule Ussmann, Birthe Schetschorke, Saskia Hell, Sebastian Schwind, Klaus H Metzeler, Marco Herling, Madlen Jentzsch, Georg-Nikolaus Franke, Ulrich Sack, Ulrike Köhl, Uwe Platzbecker, Kristin Reiche, Vladan Vucinic, Maximilian Merz
Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma. Nature cancer (2024)
C Riedhammer, F Bassermann, B Besemer, M Bewarder, F Brunner, A Carpinteiro, Hermann Einsele, J Faltin, J Frenking, D Gezer, S Goldman-Mazur, M Hänel, M Hoegner, Klaus Martin Kortüm, Jan Krönke, M Kull, T Leitner, C Mann, R Mecklenbrauck, Maximilian Merz, A Morgner, A Nogai, Marc-Steffen Raab, R Teipel, Ralph Wäsch, Leo Rasche
Real-world analysis of teclistamab in 123 RRMM patients from Germany. Leukemia 38 (2) (2024)
Maximilian Merz
A comeback for checkpoint inhibition in multiple myeloma. Nature cancer (2024)
C Riedhammer, F Bassermann, B Besemer, M Bewarder, F Brunner, A Carpinteiro, Hermann Einsele, J Faltin, J Frenking, D Gezer, S Goldman-Mazur, M Hänel, M Hoegner, Klaus Martin Kortüm, Jan Krönke, M Kull, T Leitner, C Mann, R Mecklenbrauck, Maximilian Merz, A Morgner, A Nogai, Marc-Steffen Raab, R Teipel, Ralph Wäsch, Leo Rasche
Real-world analysis of teclistamab in 123 RRMM patients from Germany. Leukemia (2024)
C Riedhammer, F Bassermann, B Besemer, M Bewarder, F Brunner, A Carpinteiro, Hermann Einsele, J Faltin, J Frenking, D Gezer, S Goldman-Mazur, M Hänel, M Hoegner, Klaus Martin Kortüm, Jan Krönke, M Kull, T Leitner, C Mann, R Mecklenbrauck, Maximilian Merz, A Morgner, A Nogai, Marc-Steffen Raab, R Teipel, Ralph Wäsch, Leo Rasche
Real-world analysis of teclistamab in 123 RRMM patients from Germany. Leukemia 38 (2) (2024)
C Riedhammer, F Bassermann, B Besemer, M Bewarder, F Brunner, A Carpinteiro, Hermann Einsele, J Faltin, J Frenking, D Gezer, S Goldman-Mazur, M Hänel, M Hoegner, Klaus Martin Kortüm, Jan Krönke, M Kull, T Leitner, C Mann, R Mecklenbrauck, Maximilian Merz, A Morgner, A Nogai, Marc-Steffen Raab, R Teipel, Ralph Wäsch, Leo Rasche
Real-world analysis of teclistamab in 123 RRMM patients from Germany. Leukemia 38 (2) (2024)
C Riedhammer, F Bassermann, B Besemer, M Bewarder, F Brunner, A Carpinteiro, Hermann Einsele, J Faltin, J Frenking, D Gezer, S Goldman-Mazur, M Hänel, M Hoegner, Klaus Martin Kortüm, Jan Krönke, M Kull, T Leitner, C Mann, R Mecklenbrauck, Maximilian Merz, A Morgner, A Nogai, Marc-Steffen Raab, R Teipel, Ralph Wäsch, Leo Rasche
Real-world analysis of teclistamab in 123 RRMM patients from Germany. Leukemia 38 (2) (2024)
Luise Fischer, Nora Grieb, Patrick Born, Ronald Weiss, Sabine Seiffert, Andreas Boldt, Stephan Fricke, Paul Franz, Simone Heyn, Anne-Sophie Kubasch, Ronny Baber, Heike Weidner, Song-Yau Wang, Enrica Bach, Sandra Hoffmann, Jule Ussmann, Janine Kirchberg, Saskia Hell, Sebastian Schwind, Klaus H Metzeler, Marco Herling, Madlen Jentzsch, Georg-Nikolaus Franke, Ulrich Sack, Kristin Reiche, Ulrike Köhl, Uwe Platzbecker, Vladan Vucinic, Maximilian Merz
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma. Leukemia (2024)
C Riedhammer, F Bassermann, B Besemer, M Bewarder, F Brunner, A Carpinteiro, Hermann Einsele, J Faltin, J Frenking, D Gezer, S Goldman-Mazur, M Hänel, M Hoegner, Klaus Martin Kortüm, Jan Krönke, M Kull, T Leitner, C Mann, R Mecklenbrauck, Maximilian Merz, A Morgner, A Nogai, Marc-Steffen Raab, R Teipel, Ralph Wäsch, Leo Rasche
Real-world analysis of teclistamab in 123 RRMM patients from Germany. Leukemia 38 (2) (2024)
Luise Fischer, Nora Grieb, Patrick Born, Ronald Weiss, Sabine Seiffert, Andreas Boldt, Stephan Fricke, Paul Franz, Simone Heyn, Anne-Sophie Kubasch, Ronny Baber, Heike Weidner, Song-Yau Wang, Enrica Bach, Sandra Hoffmann, Jule Ussmann, Janine Kirchberg, Saskia Hell, Sebastian Schwind, Klaus H Metzeler, Marco Herling, Madlen Jentzsch, Georg-Nikolaus Franke, Ulrich Sack, Kristin Reiche, Ulrike Köhl, Uwe Platzbecker, Vladan Vucinic, Maximilian Merz
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma. Leukemia 38 (2) (2024)
Luise Fischer, Nora Grieb, Patrick Born, Ronald Weiss, Sabine Seiffert, Andreas Boldt, Stephan Fricke, Paul Franz, Simone Heyn, Anne-Sophie Kubasch, Ronny Baber, Heike Weidner, Song-Yau Wang, Enrica Bach, Sandra Hoffmann, Jule Ussmann, Janine Kirchberg, Saskia Hell, Sebastian Schwind, Klaus H Metzeler, Marco Herling, Madlen Jentzsch, Georg-Nikolaus Franke, Ulrich Sack, Kristin Reiche, Ulrike Köhl, Uwe Platzbecker, Vladan Vucinic, Maximilian Merz
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma. Leukemia 38 (2) (2024)
Luise Fischer, Nora Grieb, Patrick Born, Ronald Weiss, Sabine Seiffert, Andreas Boldt, Stephan Fricke, Paul Franz, Simone Heyn, Anne-Sophie Kubasch, Ronny Baber, Heike Weidner, Song-Yau Wang, Enrica Bach, Sandra Hoffmann, Jule Ussmann, Janine Kirchberg, Saskia Hell, Sebastian Schwind, Klaus H Metzeler, Marco Herling, Madlen Jentzsch, Georg-Nikolaus Franke, Ulrich Sack, Kristin Reiche, Ulrike Köhl, Uwe Platzbecker, Vladan Vucinic, Maximilian Merz
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma. Leukemia (2024)
Luise Fischer, Nora Grieb, Patrick Born, Ronald Weiss, Sabine Seiffert, Andreas Boldt, Stephan Fricke, Paul Franz, Simone Heyn, Anne-Sophie Kubasch, Ronny Baber, Heike Weidner, Song-Yau Wang, Enrica Bach, Sandra Hoffmann, Jule Ussmann, Janine Kirchberg, Saskia Hell, Sebastian Schwind, Klaus H Metzeler, Marco Herling, Madlen Jentzsch, Georg-Nikolaus Franke, Ulrich Sack, Kristin Reiche, Ulrike Köhl, Uwe Platzbecker, Vladan Vucinic, Maximilian Merz
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma. Leukemia 38 (2) (2024)
Luise Fischer, Nora Grieb, Patrick Born, Ronald Weiss, Sabine Seiffert, Andreas Boldt, Stephan Fricke, Paul Franz, Simone Heyn, Anne-Sophie Kubasch, Ronny Baber, Heike Weidner, Song-Yau Wang, Enrica Bach, Sandra Hoffmann, Jule Ussmann, Janine Kirchberg, Saskia Hell, Sebastian Schwind, Klaus H Metzeler, Marco Herling, Madlen Jentzsch, Georg-Nikolaus Franke, Ulrich Sack, Kristin Reiche, Ulrike Köhl, Uwe Platzbecker, Vladan Vucinic, Maximilian Merz
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma. Leukemia 38 (2) (2024)
C Riedhammer, F Bassermann, B Besemer, M Bewarder, F Brunner, A Carpinteiro, Hermann Einsele, J Faltin, J Frenking, D Gezer, S Goldman-Mazur, M Hänel, M Hoegner, Klaus Martin Kortüm, Jan Krönke, M Kull, T Leitner, C Mann, R Mecklenbrauck, Maximilian Merz, A Morgner, A Nogai, Marc-Steffen Raab, R Teipel, Ralph Wäsch, Leo Rasche
Real-world analysis of teclistamab in 123 RRMM patients from Germany. Leukemia 38 (2) (2024)
Luise Fischer, Nora Grieb, Patrick Born, Ronald Weiss, Sabine Seiffert, Andreas Boldt, Stephan Fricke, Paul Franz, Simone Heyn, Anne-Sophie Kubasch, Ronny Baber, Heike Weidner, Song-Yau Wang, Enrica Bach, Sandra Hoffmann, Jule Ussmann, Janine Kirchberg, Saskia Hell, Sebastian Schwind, Klaus H Metzeler, Marco Herling, Madlen Jentzsch, Georg-Nikolaus Franke, Ulrich Sack, Kristin Reiche, Ulrike Köhl, Uwe Platzbecker, Vladan Vucinic, Maximilian Merz
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma. Leukemia 38 (2) (2024)
Bettina Glatte, Kerstin Wenk, Anja Grahnert, Maik Friedrich, Maximilian Merz, Vladan Vucinic, Luise Fischer, Kristin Reiche, Miriam Alb, Michael Hudecek, Paul Franz, Stephan Fricke, Uwe Platzbecker, Ulrike Köhl, Ulrich Sack, Andreas Boldt, Sunna Hauschildt, Ronald Weiss
Teclistamab impairs detection of BCMA CAR-T cells. Blood advances (2023)
Thomas Walter Georgi, Lars Kurch, Georg-Nikolaus Franke, Madlen Jentzsch, Sebastian Schwind, Carmen Perez-Fernandez, Naima Petermann, Maximilian Merz, Klaus H Metzeler, Gudrun Borte, Sandra Hoffmann, Marco Herling, Timm Denecke, Regine Kluge, Osama Sabri, Uwe Platzbecker, Vladan Vucinic
Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapy. Journal of cancer research and clinical oncology (2023)
Luise Fischer, Nora Grieb, Uwe Platzbecker, Vladan Vucinic, Maximilian Merz
CAR T cell therapy in multiple myeloma, where are we now and where are we heading for? European journal of haematology (2023)
Maximilian Merz, Qiang Hu, Almuth Maria Anni Merz, Jie Wang, Nicholas Hutson, Cherie Rondeau, Kimberly Celotto, Ahmed Belal, Ronald Alberico, AnneMarie Block, Hemn Mohammadpour, Paul K Wallace, Joseph D Tario, Jesse Luce, Sean T Glenn, Prashant K Singh, Mehmet Kemal Samur, Nikhil C Munshi, Song Liu, Philip L McCarthy, Lei Wei, Jens Hillengass
Spatiotemporal assessment of immunogenomic heterogeneity in multiple myeloma. Blood advances (2022)
Maximilian Merz, Almuth Maria Anni Merz, Jie Wang, Lei Wei, Qiang Hu, Nicholas Hutson, Cherie Rondeau, Kimberly Celotto, Ahmed Belal, Ronald Alberico, AnneMarie W Block, Hemn Mohammadpour, Paul K Wallace, Joseph Tario, Jesse Luce, Sean T Glenn, Prashant Singh, Megan M Herr, Theresa Hahn, Mehmet Kemal Samur, Nikhil C Munshi, Song Liu, Philip L McCarthy, Jens Hillengass
Deciphering spatial genomic heterogeneity at a single cell resolution in multiple myeloma. Nature communications 13 (1) (2022)

Maximilian Merz.css-eqlu8i{font-size:small;padding-left:4px;} (M Merz)

Publication Activity (10 Years)

Top Topics

Top Venues

Maximilian Merz (M Merz)